Terry Kim

Professor of Ophthalmology
Chief, Cornea and External Disease Service in the Department of Ophthalmology
Director, Refractive Surgery Service
Campus mail: Box 3802 Med Ctr, Durham, NC 27710
Phone: (919) 681-3568

Dr. Terry Kim, Professor of Ophthalmology at Duke University Eye Center, received his medical degree from Duke University School of Medicine and completed his residency and chief residency in ophthalmology at Emory Eye Center.  He continued with his fellowship training in Cornea, External Disease, and Refractive Surgery at Wills Eye Hospital.  He was then recruited to Duke University Eye Center, where he serves as principal and co-investigator on a number of clinical trials and research grants from the National Institutes of Health and other institutions.  Dr. Kim was formerly the Director of the Residency Program and Ophthalmology Fellowship programs and currently serves as Chief of the Cornea and External Disease Service and Director of the Refractive Surgery Service. 

Dr. Kim’s academic accomplishments include his extensive publications in the peer-reviewed literature, which include over 200 journal articles, textbook chapters, and scientific abstracts.  He is also editor and author of 3 well-respected textbooks on corneal diseases and cataract surgery.  Dr. Kim has delivered over 200 invited lectures both nationally and internationally.  He has been the recipient of the Achievement Award and the Senior Achievement Award from the American Academy of Ophthalmology (AAO).  His clinical and research work has earned him honors and grants from the National Institutes of Health, Fight for Sight/Research to Prevent Blindness, Heed Ophthalmic Foundation, Alcon Laboratories, and Allergan.  Dr. Kim is also continually listed in Best Doctors in America, Best Doctors in North Carolina, and America’s Top Ophthalmologists. He has also been voted by his peers as one of the 250 most prominent cataract and intraocular lens surgeons in the country by Premier Surgeon, as one of the “135 Leading Ophthalmologists in America” by Becker’s ASC Review, as well as one of the “Top 50 Opinion Leaders” by Cataract and Refractive Surgery Today.

Dr. Kim serves on the Governing Board for the American Society of Cataract and Refractive Surgery (ASCRS) as Chair of the Cornea Clinical Committee, on the Annual Program Committee for the AAO, and on the Executive Committee and Board of Directors for the Cornea Society.  He was recently inducted into the International Intra-Ocular Implant Club and is consultant to the Ophthalmic Devices Panel of the FDA.  Dr. Kim also sits on the Editorial Board for several peer-reviewed journals and trade publications, including Cornea, Journal of Cataract and Refractive Surgery, Ocular Surgery News, Eyeworld, Cataract & Refractive Surgery Today, Premier Surgeon, Review of Ophthalmology, Advanced Ocular Care, and Topics in Ocular Antiinfectives.  As Consultant Ophthalmologist for the Duke Men's Basketball Team, Dr. Kim provides medical and surgical care for the players, coaches, and staff, which has been featured on the Discovery Channel and The Wall Street Journal.

Education and Training

  • Duke University, M.D. 1992
  • Emory University, Resident, Ophthalmology
  • Wills Eye Hospital, Fellow in cornea and external diseases, Ophthalmology



An estimated 95 million people worldwide are affected by cataract. Cataract still remains the leading cause of blindness in middle-income and low-income countries.

Drug-induced corneal epithelial changes.

Drugs across many pharmacologic classes induce corneal epithelial changes. Many of these drugs have cationic amphiphilic structures, with a hydrophobic ring and hydrophilic cationic amine side chain that allow them to cross cell membranes.